BS MS - ScinoPharm Taiwan VP Officer

All Insiders Taiwan . 
Stock . ScinoPharm Taiwan . Stakeholders . Insider . BS MS
1789 Stock  TWD 23.40  0.05  0.21%   

Insider

BS MS is VP Officer of ScinoPharm Taiwan
Phone886 6 505 2888
Webhttps://www.scinopharm.com

ScinoPharm Taiwan Management Efficiency

The company has return on total asset (ROA) of 0.0184 % which means that it generated a profit of $0.0184 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of 0.0295 %, meaning that it generated $0.0295 on every $100 dollars invested by stockholders. ScinoPharm Taiwan's management efficiency ratios could be used to measure how well ScinoPharm Taiwan manages its routine affairs as well as how well it operates its assets and liabilities.
ScinoPharm Taiwan has accumulated 2.29 B in total debt with debt to equity ratio (D/E) of 21.1, indicating the company may have difficulties to generate enough cash to satisfy its financial obligations. ScinoPharm Taiwan has a current ratio of 3.31, suggesting that it is liquid and has the ability to pay its financial obligations in time and when they become due. Debt can assist ScinoPharm Taiwan until it has trouble settling it off, either with new capital or with free cash flow. So, ScinoPharm Taiwan's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like ScinoPharm Taiwan sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for ScinoPharm to invest in growth at high rates of return. When we think about ScinoPharm Taiwan's use of debt, we should always consider it together with cash and equity.

Similar Executives

Showing other executives

INSIDER Age

Candy ChuElite Semiconductor Memory
N/A
Samantha LinWeltrend Semiconductor
N/A
PinHsiang ChinVanguard International Semicond
N/A
Lingni ZhangNiko Semiconductor Co
N/A
Zhi WuTaiwan Semiconductor Co
N/A
HuiJung LinVanguard International Semicond
N/A
TzuChun ChenVanguard International Semicond
N/A
Janey LiuVanguard International Semicond
N/A
MingChien ChangElite Semiconductor Memory
67
ChihHong HoElite Semiconductor Memory
67
Tony LinWeltrend Semiconductor
N/A
Adam ChengTaiwan Semiconductor Co
N/A
LiChiao ChenSinopower Semiconductor
N/A
TianFure ShiueSinopower Semiconductor
N/A
John WeiVanguard International Semicond
N/A
Guo YanTaiwan Semiconductor Co
N/A
Wayne LoWeltrend Semiconductor
N/A
Robby TsaiWeltrend Semiconductor
N/A
YeongWen DaihElite Semiconductor Memory
64
HueiLan HuangVanguard International Semicond
N/A
Xing WangTaiwan Semiconductor Co
N/A
ScinoPharm Taiwan, Ltd., together with its subsidiaries, researches and develops, produces, and sells CGMP active pharmaceutical ingredients to pharmaceutical companies in Taiwan, the United States, Europe, India, rest of Asia, and internationally. ScinoPharm Taiwan, Ltd. was founded in 1997 and is headquartered in Tainan, Taiwan. SCINOPHARM TAIWAN operates under Drug Manufacturers - Specialty Generic classification in Taiwan and is traded on Taiwan Stock Exchange. ScinoPharm Taiwan (1789) is traded on Taiwan Stock Exchange in Taiwan and employs 47 people.

Management Performance

Return On Equity0.0295
Return On Asset0.0184

ScinoPharm Taiwan Leadership Team

Elected by the shareholders, the ScinoPharm Taiwan's board of directors comprises two types of representatives: ScinoPharm Taiwan inside directors who are chosen from within the company, and outside directors, selected externally and held independent of ScinoPharm. The board's role is to monitor ScinoPharm Taiwan's management team and ensure that shareholders' interests are well served. ScinoPharm Taiwan's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, ScinoPharm Taiwan's outside directors are responsible for providing unbiased perspectives on the board's policies.
Shun Lin, Director Devel
ChihHui Lin, Sr Off
ChihHsien Lo, Chairman of the Board, Chief Strategy Officer
LiAn Lu, Deputy General Manager-Administrative Management Center
Jason Chen, Director Admin
LingHsiao Lien, VicePres Operations
BS MS, VP Officer
LiChiao Chemistry, VP Officer

ScinoPharm Stock Performance Indicators

The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is ScinoPharm Taiwan a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
Return On Equity0.0295
Return On Asset0.0184
Profit Margin0.10 %
Operating Margin0.12 %
Current Valuation16.28 B
Shares Outstanding790.74 M
Shares Owned By Insiders58.97 %
Shares Owned By Institutions16.86 %
Price To Earning51.64 X
Price To Book1.92 X

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
VVisa Class A
GOOGAlphabet Inc Class C
GOOGAlphabet Inc Class C

Additional Tools for ScinoPharm Stock Analysis

When running ScinoPharm Taiwan's price analysis, check to measure ScinoPharm Taiwan's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy ScinoPharm Taiwan is operating at the current time. Most of ScinoPharm Taiwan's value examination focuses on studying past and present price action to predict the probability of ScinoPharm Taiwan's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move ScinoPharm Taiwan's price. Additionally, you may evaluate how the addition of ScinoPharm Taiwan to your portfolios can decrease your overall portfolio volatility.
Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions
 
Feedback Blog
Made with optimal in San Francisco
2024 Macroaxis LLC
COMMON DESTINATIONS
MAIN CATEGORIES
COMPANY